| | | Deletion | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | not provided +1 more | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (nonsense) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +2 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Skin/hair/eye pigmentation, variation in, 2 +5 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +5 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +1 more | |
| | | Single nucleotide variant (synonymous variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (missense variant) | Increased analgesia from kappa-opioid receptor agonist, female-specific +4 more | |
| | | Single nucleotide variant (synonymous variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Melanoma +2 more | GConflicting classifications of pathogenicity; risk factor |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not specified +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +1 more | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |